Breast Cancer

Study demonstrates clear survival benefit of treatment in clinical trials

Published in Clinical Oncology Week, April 5th, 2004

A new study from Canada has found that breast cancer patients who were treated according to accepted standards of care or who took part in clinical trials were from 30% to 60% less likely to die from any cause during a 7-year follow up period.

Lead researcher Nicole Hebert-Croteau, MD, told the 4th European Breast Cancer Conference on March 19, 2004, that the findings, while not statistically different, confirmed the assumption that breast cancer patients benefited from taking part in clinical trials. Treatment in centers that dealt with large numbers of cases was also associated with better survival.

Hebert-Croteau and her team studied 1,727 women...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2004-04-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry